Involvement of SSAO/VAP-1 in Oxygen-Glucose Deprivation-Mediated Damage Using the Endothelial hSSAO/VAP-1-Expressing Cells as an Experimental Model of Cerebral Ischemia

Publisher： Karger

E-ISSN： 1421-9786|37|3|171-180

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.37, Iss.3, 2014-02, pp. : 171-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

VAP-1/SSAO Plasma Activity and Brain Expression in Human Hemorrhagic Stroke

By  

Cerebrovascular Diseases, Vol. 33, Iss. 1, 2011-12 ,pp. : 55-63

Karger

Access to resources Recommend Favorite

Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner

By Abella A.   García-Vicente S.   Viguerie N.   Ros-Baró A.   Camps M.   Palacín M.   Zorzano A.   Marti L.  

Diabetologia, Vol. 47, Iss. 3, 2004-03 ,pp. : 429-438

Springer Publishing Company

Access to resources Recommend Favorite

Cerebral Blood Flow, Glucose Metabolism and TUNEL-Positive Cells in the Development of Ischemia

By  

Cerebrovascular Diseases, Vol. 11, Iss. 1, 2001-01 ,pp. : 9-19

Karger

Access to resources Recommend Favorite

Interleukin-8-Induced Proliferation, Survival, and MMP Production in CXCR1 and CXCR2 Expressing Human Umbilical Vein Endothelial Cells

By Li A.   Dubey S.   Varney M.L.   Singh R.K.  

Microvascular Research, Vol. 64, Iss. 3, 2002-11 ,pp. : 476-481

Academic Press

Access to resources Recommend Favorite

Hyperbaric Oxygen Therapy of Cerebral Ischemia

By  

Cerebrovascular Diseases, Vol. 20, Iss. 6, 2005-11 ,pp. : 417-426

Karger

Access to resources Recommend Favorite